Business Litigation Article Archives
July, 2017 | By J. Snowden Stanley, Jr.
This article offers Maryland contractors and subcontractors a practical outline of some of the legal principles applicable to their daily business activities in an effort to help them anticipate problems and to be better equipped to resolve potential disputes with a minimum of difficulty and expense. A limited outline such as this cannot provide legal…
The “Right to Try” refers to the right of terminally or seriously ill patients to acquire investigational drugs without waiting for FDA approval. It grants these patients the right to access certain drugs, specifically those drugs that have completed only phase one of the FDA three-phase drug approval process. Advocates of the Right to Try contend that the decision to try an investigational drug should be between a patient and his or her physician and, thus, exclude the government, i.e., the FDA. Opponents support the FDA’s role in the drug approval and distribution process. The Right to Try debate boils down to one question: Who should decide whether a drug is too risky to try?
Maryland Defense Counsel’s (“MDC”) lobbyists have been busy monitoring the bills affecting its members during the 2014 General Assembly Session. John Stierhoff, Ileen Ticer, Gardner Duvall, Mike Dailey, Chris Boucher and Nikki Nesbitt are among those who have testified or are expected to testify and propose amendments to certain bills. Highlighted below are some of the bills on which MDC acted.
This brave new world of social media poses a host of challenges, both substantive and procedural, for judges, attorneys, and litigants. Though some have refused to recognize the reality of social media,6 most jurists and attorneys are now dealing head-on with issues raised by its use. By Marisa A. Trasatti and Anna C. Horevay. View…